Cantitate/Preț
Produs

Aniridia: Recent Developments in Scientific and Clinical Research

Editat de Mohit Parekh, Barbara Poli, Stefano Ferrari, Corrado Teofili, Diego Ponzin
en Limba Engleză Hardback – 8 sep 2015
The aim of this book is to highlight the latest findings in Aniridia research. Aniridia, meaning “without iris”, is a rare genetic disorder affecting vision, characterized by the incomplete formation of the iris (the coloured part of the eye that surrounds the black pupil). It may also cause other segments of the eye to be under-developed such as the optic nerve and the macula (the central part of the retina). Aniridia and associated conditions affect individuals differently. So while some affected people are partially sighted or blind, others may have near normal sight. Aniridia is congenital (present at birth) and is caused by a dysfunction of the PAX6 gene, situated on the 11th chromosome that causes the premature cessation of eye development. Aniridia affects between 1:40,000 to 1:100,000 people, and affects males and females equally. People with Aniridia may also experience secondary conditions such as Photophobia, Nystagmus, Glaucoma, Cataracts and Keratopathy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 65557 lei  38-44 zile
  Springer International Publishing – 22 oct 2016 65557 lei  38-44 zile
Hardback (1) 71041 lei  22-36 zile
  Springer International Publishing – 8 sep 2015 71041 lei  22-36 zile

Preț: 71041 lei

Preț vechi: 74780 lei
-5% Nou

Puncte Express: 1066

Preț estimativ în valută:
13596 14123$ 11293£

Carte disponibilă

Livrare economică 13-27 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319197784
ISBN-10: 3319197789
Pagini: 200
Ilustrații: VIII, 192 p. 57 illus., 54 illus. in color.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.65 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

Preface.- What is Aniridia: Epidemiology, clinical features and genetic implications.- Optical Coherence Tomography imaging in patients with PAX6 mutations.- Aniridic Glaucoma: Diagnosis and Treatment.- Management of Glaucoma in Congenital Aniridia.- Clinical and surgical management of cataract in congenital aniridia.- The ocular surface in aniridia.- Aniridic Keratopathy: Conservative approaches.- Lamellar and penetrating keratoplasty in congenital aniridia.- Boston KPRo Type I as a viable alternative to visual rehabilitation in aniridia patients: advances and limitations.- Cell therapy for regeneration of the corneal epithelium aniridic patients.- Strategies for success in limbal allograft transplantation for aniridia.- The paediatric patient: identifying congenital aniridia as soon as possible.- Early diagnosis: the key roles of neonatologists, paediatricians and paediatric ophthalmologists.- Aniridia guides and aniridia-syndrome (Pax6-Syndrome).- Assessing the visual function in congenital aniridia and following the child during daily life.- Children with aniridia and healthcare systems: from needs assessment to a comprehensive programme of care and assistance.- European/international guidelines on Aniridia: the patients’ point of view.- What to do when diagnosed with Aniridia: the role of patients´ associations.- Conclusions and future perspectives.- Index.

Textul de pe ultima copertă

​ The aim of this book is to highlight the latest findings in Aniridia research. Aniridia, meaning “without iris”, is a rare genetic disorder affecting vision, characterized by the incomplete formation of the iris (the coloured part of the eye that surrounds the black pupil). It may also cause other segments of the eye to be under-developed such as the optic nerve and the macula (the central part of the retina). Aniridia and associated conditions affect individuals differently. So while some affected people are partially sighted or blind, others may have near normal sight. Aniridia is congenital (present at birth) and is caused by a dysfunction of the PAX6 gene, situated on the 11th chromosome that causes the premature cessation of eye development. Aniridia affects between 1:40,000 to 1:100,000 people, and affects males and females equally. People with Aniridia may also experience secondary conditions such as Photophobia, Nystagmus, Glaucoma, Cataracts and Keratopathy.

Caracteristici

Current Research Dedicated To The Ocular Defects Of Aniridia Latest Surgical Approaches Special Attention To Pediatric Patients